Rapid method for measurement of bronchial responsiveness

Area of Science:

• Pulmonology
• Allergy and Immunology
• Respiratory Medicine

Background:

• Assessing bronchial hyperresponsiveness is crucial for diagnosing and managing respiratory conditions.
• Existing methods for measuring bronchial responsiveness can be time-consuming or complex.
• Histamine inhalation challenges are a standard tool for evaluating airway reactivity.

Purpose of the Study:

• To describe and validate a rapid, simple method for measuring bronchial responsiveness to inhaled histamine.
• To assess the correlation between bronchial responsiveness and symptom severity in atopic subjects.
• To evaluate the reproducibility and accuracy of the novel method compared to existing techniques.

Main Methods:

• A rapid, simple method was developed to measure bronchial responsiveness using inhaled histamine.
• Dose-response curves were generated in 50 atopic subjects with diverse respiratory and nasal symptoms.
• The cumulative dose of histamine causing a 20% fall in one-second forced expiratory volume (PD20-FEV1) was determined.
• Reproducibility was assessed through duplicate measurements in 15 subjects.
• The novel method was compared against a standard dosimeter method.

Main Results:

• The PD20-FEV1 values ranged from 0.046 to over 3.9 mumol, showing significant variability.
• A strong correlation was observed between PD20-FEV1 and the severity of respiratory and nasal symptoms.
• Duplicate measurements demonstrated satisfactory reproducibility of the PD20-FEV1.
• No significant difference was found when comparing the PD20-FEV1 from the rapid method to the dosimeter method.
• The delivered dose in the rapid method was confirmed to be cumulative.

Conclusions:

• The developed rapid method provides a reliable and simple approach for assessing bronchial responsiveness to histamine.
• This method effectively correlates histamine airway reactivity with symptom severity in atopic individuals.
• The satisfactory reproducibility and comparability to the dosimeter method support its clinical utility for diagnosing and managing airway hyperresponsiveness.